Cipla receives USFDA approval for its generic cancer treatment drug, paclitaxel protein-bound particles, a therapeutic equivalent to Bristol Myers Squibb's Abraxane. The drug is expected to launch in ...

In December of 2021, Amsterdam-based argenx scored its first-ever FDA approval with Vyvgart, a first-in-class FcRn inhibitor. Until Vyvgart's approval, doctors had to rely on surgery, steroids and ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus FDA-approved, standard of care treatments Acyclovir and Abreva in a preclinical animal model.

FDA grants full approval to Bayer's Vitrakvi for NTRK fusion-positive solid tumors in adults and children. Clinical trials show a 60% overall response rate and median response duration of 43.3 ...

Vitrakvi received full FDA approval for treating NTRK gene fusion-positive solid tumors in adults and children, following its initial accelerated approval in 2018. The drug functions as a tyrosine ...

To get FDA approval, scientists must be able to demonstrate that a new drug or treatment is safe and effective. And currently, before they can test a new therapy in humans, they must show proof ...

The FDA has fully approved larotrectinib for adult and pediatric patients with solid tumors that harbor an NTRK gene fusion. The FDA has granted full approval to larotrectinib (Vitrakvi) for patients ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been approved by the US Food and Drug Administration (FDA) as a first-line treatment for colorectal cancer (CRC).

Denver City Council has approved new funding to go toward more art projects at the 16th Street Mall to be completed by December 2027. Ex-Trump Official Reacts to Executive Order That Targets Him ...

The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox and mpox vaccine, live, non-replicating). Prior to this approval, Jynneos had only been ...

In the coming weeks, the Food and Drug Administration is expected to make a decision ... Arcutis Biotherapeutics is seeking to expand the approval of roflumilast foam to include the treatment of ...

Tesamorelin for injection is approved in the U.S. for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy*. Tesamorelin for injection is a growth hormone ...